BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33457007)

  • 1. CXCL5/CXCL8 is a promising potential prognostic and tumor microenvironment-related cluster in hepatocellular carcinoma.
    Zhu J; Zhou Y; Wang L; Hao J; Chen R; Liu L; Li J
    J Gastrointest Oncol; 2020 Dec; 11(6):1364-1380. PubMed ID: 33457007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinoma.
    Wang T; Chen B; Meng T; Liu Z; Wu W
    Bioengineered; 2021 Dec; 12(1):1555-1575. PubMed ID: 33955820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.
    Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z
    Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309
    [No Abstract]   [Full Text] [Related]  

  • 5. An investigation to identify tumor microenvironment-related genes of prognostic value in lung squamous cell carcinoma based on The Cancer Genome Atlas.
    Liu H; Liu B; Zhang L; Li M; Chen C; He S; Luo T; He X; Tan L
    Transl Cancer Res; 2021 Apr; 10(4):1885-1899. PubMed ID: 35116510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates.
    Nie Y; Jiang MC; Liu C; Liu Q; Zhu X
    Front Oncol; 2021; 11():637023. PubMed ID: 33869023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
    Wang L; Wang L; He P
    Front Genet; 2022; 13():1064432. PubMed ID: 36568383
    [No Abstract]   [Full Text] [Related]  

  • 9. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
    Shi T; Gao G
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.
    Huang S; Zhang J; Lai X; Zhuang L; Wu J
    Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851
    [No Abstract]   [Full Text] [Related]  

  • 11. The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy.
    Zou R; Liu Y; Qiu S; Lu Y; Chen Y; Yu H; Zhu H; Zhu W; Zhu L; Feng J; Han J
    Cancer Biomark; 2023; 38(4):551-566. PubMed ID: 38007640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma.
    Pan B; Yang M; Wei X; Li W; Wang K; Yang M; Lu D; Wang R; Cen B; Xu X
    Aging (Albany NY); 2021 Jul; 13(14):18620-18644. PubMed ID: 34282055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening TCGA database for prognostic genes in lower grade glioma microenvironment.
    Ni J; Liu S; Qi F; Li X; Yu S; Feng J; Zheng Y
    Ann Transl Med; 2020 Mar; 8(5):209. PubMed ID: 32309356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
    Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
    Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
    [No Abstract]   [Full Text] [Related]  

  • 15. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
    Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
    Front Immunol; 2022; 13():950213. PubMed ID: 36072582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients.
    Ye D; Liu Y; Li G; Sun B; Peng J; Xu Q
    Front Oncol; 2021; 11():766072. PubMed ID: 34868990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
    Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
    Front Genet; 2021; 12():682082. PubMed ID: 34745200
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis.
    Zhu W; Ru L; Ma Z
    Front Oncol; 2021; 11():626654. PubMed ID: 33777771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.
    Li R; Zhao W; Liang R; Jin C; Xiong H
    Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972
    [No Abstract]   [Full Text] [Related]  

  • 20. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.